BostonSight Announces Key Findings in Using PROSE for the Treatment of Neurotrophic Keratitis
NEEDHAM, MA, UNITED STATES, July 28, 2026 /EINPresswire.com/ -- BostonSight® announced key findings in the use of PROSE® for the treatment of neurotrophic keratitis (NK) in a poster presented at the Association for Research in Vision and Ophthalmology’s …